110 related articles for article (PubMed ID: 26056130)
1. Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGFβ Signaling Pathway.
Desnoyers G; Frost LD; Courteau L; Wall ML; Lewis SM
Mol Cancer Res; 2015 Oct; 13(10):1421-30. PubMed ID: 26056130
[TBL] [Abstract][Full Text] [Related]
2. Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells.
Gillis LD; Lewis SM
Oncogene; 2013 Aug; 32(31):3598-605. PubMed ID: 22907435
[TBL] [Abstract][Full Text] [Related]
3. The Possible Role of Eukaryotic Translation Initiation Factor 3 Subunit e (eIF3e) in the Epithelial-Mesenchymal Transition in Adenomyosis.
Cai X; Shen M; Liu X; Nie J
Reprod Sci; 2019 Mar; 26(3):377-385. PubMed ID: 29871559
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
[TBL] [Abstract][Full Text] [Related]
6. Reduced Expression of Eukaryotic Translation Initiation Factor 3 Subunit e and Its Possible Involvement in the Epithelial-Mesenchymal Transition in Endometriosis.
Cai X; Shen M; Liu X; Guo SW
Reprod Sci; 2018 Jan; 25(1):102-109. PubMed ID: 28438065
[TBL] [Abstract][Full Text] [Related]
7. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
8. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
9. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
10. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
11. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
[TBL] [Abstract][Full Text] [Related]
12. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors.
Zhao L; Liu S; Che X; Hou K; Ma Y; Li C; Wen T; Fan Y; Hu X; Liu Y; Qu X
Int J Mol Med; 2015 Sep; 36(3):645-52. PubMed ID: 26133118
[TBL] [Abstract][Full Text] [Related]
13. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
Serrano I; McDonald PC; Lock FE; Dedhar S
Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
[TBL] [Abstract][Full Text] [Related]
14. An oncogenic role of eIF3e/INT6 in human breast cancer.
Grzmil M; Rzymski T; Milani M; Harris AL; Capper RG; Saunders NJ; Salhan A; Ragoussis J; Norbury CJ
Oncogene; 2010 Jul; 29(28):4080-9. PubMed ID: 20453879
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
16. INT6/eIF3e represses E-cadherin expression through HIF2α in lung carcinoma A549 cells.
Gotoh-Saito S; Sadato D; Shibasaki F
Genes Cells; 2022 Dec; 27(12):689-705. PubMed ID: 36116043
[TBL] [Abstract][Full Text] [Related]
17. Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition.
Prasanphanich AF; Arencibia CA; Kemp ML
Free Radic Biol Med; 2014 Nov; 76():1-13. PubMed ID: 25088330
[TBL] [Abstract][Full Text] [Related]
18. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
19. Leptin promotes metastasis by inducing an epithelial-mesenchymal transition in A549 lung cancer cells.
Feng H; Liu Q; Zhang N; Zheng L; Sang M; Feng J; Zhang J; Wu X; Shan B
Oncol Res; 2013; 21(3):165-71. PubMed ID: 24512731
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
